Loading ...
Sorry, an error occurred while loading the content.

Rosacea News August 2013

Expand Messages
  • David Pascoe
    1. Mirvaso Before and After Pictures What sort of benefit might you expect from using Mirvaso to treat your rosacea redness? Well, Galderma has made available
    Message 1 of 1 , Oct 2, 2013
    • 0 Attachment
      1. Mirvaso Before and After Pictures

      What sort of benefit might you expect from using Mirvaso to treat your rosacea redness? Well, Galderma has made available some publicity photographs that show before and after photographs from the Mirvaso Clinical Trials; Quite impressive, don't you think ?


      2. Skinova helps rosacea with Ultrasound Skin Treatments at home

      A recently published paper introduces us to a new form of at-home therapy based on high frequency ultrasound. The Skinova treatment using sound waves at a very high frequency of 10 MHz. This allows treatments to a depth of around 0.3cm. At this depth we are told that the effect is mainly concentrated on the ...


      3. Mirvaso Ingredients

      The just approved Mirvaso is a milestone in the long development and approval process. Rosacea sufferers have watched this drug since as early as 2004 when patents started emerging. Now that Mirvaso has been officially approved by the FDA more information about the final formulation has emerged. From the Mirvaso Prescribing Information we can see ...


      4. Mirvaso (Sansrosa, Brimonidine) Approved for Rosacea Redness

      News today that Galderma has succeeded in gaining FDA Approval for Mirvaso  the brand name chosen for the product that during development was known as Sansrosa, CD07805/47 and Col-118. The Brimonidine Tartrate 0.33% Topical Gel is expected to be available as soon as next month. Great news that approval has been granted after so ...


      5. Step backwards for Generic Oracea. Invalid patents are back

      For those following the saga of the possible availability of Generic Oracea in the future, another twist today. Two of the patents that were previously ruled invalid and thus unable to protect Galderma's product, have now been ruled no longer invalid. This legal ruling will no doubt embolden Galderma that their profitable product Oracea can ...


      6. Patent: Combining Sansrosa and Finacea

      Galderma is staking out its claim on potential rosacea topicals with another patent being published. This patent details potential topicals that are combinations of the active ingredients in Sansrosa and Finacea, namely Brimonidine Tartrate and Azelaic Acid. The touted benefits from combining the two actives is a reduction in rebound redness and a greater tolerance ...


      7. Generic Oracea one step closer, Lupin gets Tentative FDA Approval

      News today that Lupin has been granted tentative approval by the FDA to product a generic version of Oracea. We learn in 2010 that Lupin had filed an abbreviated new drug application to make generic Oracea. Lupin Pharmaceuticals, based in Mumbai India is a company specialising in the production of generic medicines. It has been ...



      --
      David Pascoe, pascoedj@...
    Your message has been successfully submitted and would be delivered to recipients shortly.